Join us for a two-day immersion in essentials on core topics related to Healthcare Innovation and Entrepreneurship in the Widmer Wing Auditorium on September 14th and 15th.
Two full days including talks on:
- Ideating for Scale
- Transitioning from Innovation to Entrepreneurship
- Healthcare Innovation Development and Regulatory Concerns
- Intellectual Property Considerations
- Identifying your Target Market
- Developing your Team
- Understanding your Competitive Advantage in the Market
- Financing your Startup and Sales
- Ethical Considerations
- Characteristics for Success
- The Art of Pitching
Admission is free for UConn affiliates!
Only 20 slots are available, so register right away!
When and Where
September 14-15, 2019
Saturday: 8 a.m. to 5 p.m.
Sunday: 8 a.m. to 4 p.m.
UConn School of Nursing
Storrs Hall, Widmer Wing Auditorium
231 Glenbrook Ave
Mostafa Analoui, Ph.D.
Mostafa Analoui, Ph.D., is Executive Director of Venture Development and Technology Incubation Program (TIP) at UConn. Previously, he was Head of Healthcare and Life Sciences at Livingston Securities (New York, NY) with investment focus in private and public companies in biotech, medtech and healthcare services. Prior to that, he was the Senior Director at Pfizer Global Research and Development. Dr. Analoui is actively involved in investment, management and scientific/business development of nanotechnology, drug discovery/development, diagnostic imaging, and global strategies.
While at Pfizer, he was the Site Head for Global Clinical Technology in Groton and New London, a division focusing on emerging technologies for development and validation of biomarkers and diagnostics for drug development. Prior to joining Pfizer, Analoui was the Director of Oral and Maxillofacial Imaging Research, Associate Professor of Radiology at Indiana University, and Associate Professor of Biomedical Engineering and Electrical & Comp Engineering at Purdue University. He was also President and CEO of Therametric Technology Inc. He has received his Ph.D. from Purdue University, followed by Post-Doctoral Fellowship at IBM TJ Watson Research Center in NY.
In addition to industry leadership in biomedical and technology fields, he consults and lectures in US, Europe and Asia. He has also served on various scientific, regulatory, and business advisory committees and boards, including NIH, NSF, PhRMA, NASA, and OECD. Analoui has authored over 130 publications, including journal articles, a book and book chapters and technical reports. Analoui is currently Adjust Professor at University of Connecticut (Storrs/Farmington, CT), Brown University (Providence, RI), and Northeastern University (Boston, MA). He is also senior member of IEEE, SPIE, and RSNA.
He was Chairman of the Board of VirtualScopics (NASDAQ: VSCP) and currently serves as Chairman of the Board member of Cyclica, member of the board of Connecticut Innovations, and NanoBusiness Commercialization Association.
Kevin Bouley is President and CEO of Nerac, Inc., a global technology and IP advisory research firm.
Kevin is an active Angel investor, nurturing innovation, investing in numerous new technology-based ventures. He supports the CT startup community and chairs bi-monthly XcellR8 meetings, assisting and advising early stage entrepreneurs. Kevin is active in entrepreneurial activities at UConn, including Innovation Quest, the Werth Institute for Innovation and Entrepreneurship, Nursing Innovations and supports the Innovation Partnership Building.
Kevin is presently on the UConn School of Engineering Advisory Board, the UConn School of Business Advisory Cabinet and formerly served on the boards of the Connecticut Technology Council (CTC) and the Connecticut Business and Industry Association (CBIA). Kevin received the UConn Alumni Association 2007 University Service Award, the UConn School of Engineering 2010 Distinguished Service Award, and was inducted into the UConn School of Business 2014 Hall of Fame, among many others.
Anna Bourgault, RN, MSN, CCRC
Anna Bourgault is an Assistant Professor in the SON at UConn. She has been engaged with the Health Care Innovation Program specifically for undergraduate students since 2014. The program was originally immersed in the classroom format with several groups of students collaborating with other UConn undergraduate disciplines. The program for undergraduate students is now an independent study course that continues to attract future nursing innovators. These students have received grants to support the development of their innovative ideas, participated as a speaker for the Connecticut Nursing Association, collaborated with a start-up company and several have received paid summer internships and employment offers prior to graduation. Anna has assisted at three HackUconn sponsored by the Werth Institute for Entrepreneurship & Innovation at UConn; students from several disciplines form teams to identify creative solutions to the HackUconn theme problem. The most recent themes ranged from addressing sports and gaming experience to this year’s healthcare and technology innovative ideas.
Anna received the bug for Innovation when asked to become an assistant manager for a Transitional Unit at a Health Maintenance Organization in Southern California. The Transitional Unit was a new model of delivering care that would keep members in network for sub-acute needs. A nursing team approach in delivering care was implemented with the collaboration of a team of health care professionals. Other innovative experiences were through device and system development opportunities learned as a seasoned ICU nurse and managing pharmaceutical clinical trials in the ICU, Orthopedics, Surgical and outpatient setting. It has been clear to Anna that there is not only one way of delivering care and the next innovative idea is just around the corner.
Gregory Gallo, Ph.D.
Gregory Gallo received a B.S. degree in Biology at Lafayette College in 1983 and subsequently completed a Ph.D. in Molecular Biology at the University of Pennsylvania in 1988. Gallo continued his formal studies at Harvard University/Massachusetts General Hospital as a recipient of the Inaugural Lawton Chiles Post-Doctoral Fellowship in Biotechnology.
Upon completion of his post-doctoral studies, Gallo entered the biotechnology industry as a research scientist working in the areas of antibody humanization and regulation of programmed cell death at T Cell Sciences, Inc., ImmunoGen, Inc. and Apoptosis Technologies, Inc. In 1996, Gallo moved to the Pharmaceutical Division of Bayer Corporation where he was involved with small-molecule drug discovery in the cancer, diabetes, and obesity programs. Gallo joined the University of Connecticut in 2002 as the Licensing Director for Life Sciences, responsible for the evaluation, protection and licensing of life sciences-related intellectual property generated at the university and today oversees the technology transfer operations as the Director of Technology Transfer.
Tiffany Kelley, Ph.D, MBA, RN
Tiffany Kelley is the DeLuca Foundation Visiting Professor for Innovations and New Knowledge at the University of Connecticut School of Nursing. Kelley was appointed to this role in August 2018. She is charged with developing and executing a strategic plan to foster innovation across academic programs and develop the Healthcare Innovation Certificate Program starting in January 2020. Kelley is a leading expert on the topics of healthcare innovation and informatics in the contemporary times of delivering safe, efficient, timely, patient-centered, effective and equitable care to patients and their families. By preparing our nursing students and current nurses with the appropriate knowledge, skills and attitudes toward innovative behaviors and culture, we hold the potential to drive significant positive change in the profession of nursing and healthcare at large. Kelley is also an active healthcare innovator and entrepreneur. She is the Founder & CEO of Nightingale Apps and iCare Nursing Solutions. She is a published author, international keynote speaker, and thought leader committed toward improving on limitations within the status quo. Kelley is the author of Electronic Health Records or Quality Nursing and Health Care, a textbook offering comprehensive insights on the complex tool we are dependent upon today as health care professionals. Kelley currently serves as an Advisor for Northeastern University's Healthcare Innovation and EntrepreNURSEship Board and is the current President-Elect of the American Nurses Association of Massachusetts. In 2017, Kelley was recognized as one of the top 12 women in healthcare and awarded Excellence in Innovation for Nightingale Apps' Know My Patient in 2018.
Ruth Lucas, Ph.D., RN
My innovation focuses on developing a biomedical device and clinical psychosocial interventions that support maternal and infant health, specifically breastfeeding. I am a nurse scientist with more than 20 years of clinical experience in maternal child health. My innovation was triggered by identifying a gap in clinical practice. To address this gap, I have learned many skills, including obtaining my Ph.D., pilot testing individual features of our Breastfeeding Diagnostic Device (BDD) and founding Dyadic Innovations, LLC with my colleague, Jimi Francis, Ph.D., RNC, IBCLC. We learn something new every day. As my team and I continue developing and testing the BDD device, we have interviewed mothers, clinicians, engineers, potential sponsors and industry partners. My team and I have been funded by the Connecticut BioScience Pipeline Grant, Accelerate UConn, the Connecticut Center for Entrepreneurship and Innovation Summer Fellowship, UConn’s Office of the Vice President of Research START grant, and internal research grants from the University of Texas at Tyler. We have conducted initial field-testing of the BDD, but we are testing our newest prototype in the lab. Our goal is to have a minimal viable product to trial in the clinical setting within two years supported by government and industry funding.
Christine Meehan, MA, RN
Christine W. Meehan is a nurse, an entrepreneur and angel investor in women owned medical companies. She graduated from the University of Connecticut with a BSN and went on to take her Masters from NYU and is currently an Adjunct Professor and Entrepreneur in Residence at the University of Connecticut, School of Nursing. Following a 12-year career in ICU and Hematology/Oncology Nursing in the Boston area, she went to work for a medical device startup in the Boston area. Over the next 25 years, she rose thru the ranks of a variety of medical companies to become senior management. She then started her own medical device company, which was successfully divested. Following that event, she became an angel investor in women owned startup healthcare companies. Most recently in 2012 at the UConn School of Nursing, her Alma Mater, she initiated the Healthcare Innovation Program with other faculty to teach undergraduate nursing students the basics of innovation and entrepreneurship in a healthcare setting. She is an invited lecturer at various Nursing Innovation conferences in the US including the Cleveland Clinic Innovation Program, The Marie Gustin Conference, Venturewell, UMass Boston, and Northeastern University Innovation Summit. In addition, in 2011, she was awarded UConn SON’s Carol Ladd Widmer Outstanding Alumni Award for Leadership in Nursing for her work promoting nursing innovation and entrepreneurship. In 2017, she was recognized as one of the 75 Difference Makers in the 75-year history of the UConn School of Nursing.
David Noble, Ph.D.
David Noble was appointed the inaugural Director of The Werth Institute in January 2018, previously he served as the co-director of the Entrepreneurship & Innovation Consortium and the xCITE: Women in Innovation, Technology, and Entrepreneurship Conference. As a faculty member in the School of Business, he teaches courses on technology innovation and entrepreneurship. David is an active mentor at UConn, and has recently founded Zatoichi Co., a blockchain based startup.
Prior to UConn, David was a securities and corporate finance attorney, with experience representing startups from formation through the IPO process. He has extensive non-profit board experience. He holds a Ph.D. in Management from the University of Alabama, a J.D. from the University of Miami, an M.B.A. from Elon University, and a B.S. in Political Science from Northeastern University.